DJIA 16,982.59 22.02 0.13%
NASDAQ 4,444.91 -4.66 -0.10%
S&P 500 1,978.91 0.57 0.03%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)



company name or ticker
Company Photos
(Click to zoom)

BIND Therapeutics Ends Oncology Deal with Amgen - Analyst Blog

Sector Update: Healthcare Stocks Slightly Higher; BIND Therapeutics Drops Partnership with Amgen on

Sector Update: Healthcare Stocks Slightly Higher; BIND Therapeutics Drops Partnership with Amgen on Cancer Treatment

Sector Update: Healthcare

3 Stocks Underperforming Today In The Health Care Sector

Pfizer Has It All Wrong, Should Look Into New Viable Acquisitions

Alcatel Lucent Leads Gains Among European ADRs on Upgrade by J.P. Morgan

AstraZeneca (AZN) Showing Signs Of Being A Momo Momentum Stock

AstraZeneca's Olaparib Fails to Impress FDA Panel - Analyst Blog

AstraZeneca's Olaparib Fails to Impress FDA Panel - Analyst Blog

Sector Update: Healthcare; Cipher Pharmaceuticals Names New CEO, Valeant Bid For Allergan May Get Bo

Sector Update: Healthcare; Cipher Pharmaceuticals Names New CEO, Valeant Bid For Allergan May Get Boost As Paulson & Co Buys Stake in Botox Maker

Ligand Pharma-TG Therapeutics Collaborate on IRAK4 Inhibitors - Analyst Blog

See More Articles...